Cabaletta Bio
CABA
92 hedge funds and large institutions have $50.3M invested in Cabaletta Bio in 2025 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 28 increasing their positions, 33 reducing their positions, and 30 closing their positions.
51% more call options, than puts
Call options by funds: $463K | Put options by funds: $307K
4.36% less ownership
Funds ownership: 78.63% → 74.27% (-4.4%)
15% less funds holding
Funds holding: 108 → 92 (-16)
15% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 33
42% less capital invested
Capital invested by funds: $87.2M → $50.3M (-$36.9M)
50% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 30
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SSA
Schonfeld Strategic Advisors
New York
|
+$3.54M |
| 2 |
CF
Cantor Fitzgerald
New York
|
+$2.95M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$932K |
| 4 |
AC
Almitas Capital
Santa Monica,
California
|
+$783K |
| 5 |
IHAM
Integral Health Asset Management
New York
|
+$746K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
-$3.92M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.87M |
| 3 |
Two Sigma Investments
New York
|
-$917K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$797K |
| 5 |
SCM
Superstring Capital Management
New York
|
-$774K |
CABA Hedge Fund Activity: Q1 2025 in Review
92 of the 7,463 institutional investors tracked by Wall St. Rank reported a position in Cabaletta Bio (CABA) for Q1 2025, worth a combined $50.3M — down 42% from $87.2M a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of CABA and 15 opened new positions — a net loss of 15 holders — while 33 trimmed existing stakes and 28 added.
The largest buyer was Schonfeld Strategic Advisors, opening a new position worth an estimated $3.54M. The largest seller was Fred Alger Management, cutting an estimated $3.92M.
- 92 institutional investors held Cabaletta Bio (CABA) as of Q1 2025, down from 108 in Q4 2024.
- Funds reported $50.3M of Cabaletta Bio stock for Q1 2025, down 42% quarter-over-quarter.
- 15 funds opened new Cabaletta Bio positions in Q1 2025 and 30 closed out, a net change of -15 holders.
- The largest Cabaletta Bio buyer in Q1 2025 was Schonfeld Strategic Advisors, an estimated $3.54M added.
- The largest Cabaletta Bio seller in Q1 2025 was Fred Alger Management, an estimated $3.92M sold.
Based on aggregated 13F filings for Q1 2025.